Global Pulse Oximeter Market Size, Share, Opportunities, And Trends By Type (Fingertip Pulse Oximeter, Handheld Oximeter, Fetal Pulse Oximeter, Tabletop Pulse Oximeter, Wristband Pulse Oximeter, Pediatric Pulse Oximeter), By End-User (Hospital & Clinics, Ambulatory Surgery Center, Home Care), And By Geography - Forecasts From 2025 To 2030

The global pulse oximeter market is projected to grow at a CAGR of 5.59% during the forecast period.

Pulse Oximeters work on the principle of pulse oximetry, which is used to determine the fraction of oxygen-saturated haemoglobin concerning the total haemoglobin. Pulse Oximeters are widely used in the healthcare industry for monitoring the blood oxygen levels of patients, in emergencies, operations, and intensive care units, thereby boosting the market growth. Also, factors such as declining cost and improving result precision will further fuel the market growth. The North American region is expected to witness high growth due to the presence of a strong healthcare industry coupled with a favourable innovation environment and huge research and development expenditure.

The market is significantly impacted by the rise in awareness about pulse oximeters amongst customers and with the ongoing technological advancements being done in the sector, the market is expected to grow further in the coming years. The availability of new products and high unmet needs in developing and least-developed economies are expected to boost market growth over the forecast period. Around 43 states in the U.S. have made pulse oximetry mandatory for newborn screening and is gaining popularity in other countries due to applications in the detection of Congenital Heart Defects (CHD) and other heart and respiratory conditions.

The growing prevalence of target diseases such as asthma, hyperlipidemia, hypertension, diabetes, ischemic conditions, cardiac arrhythmia, sleep apnea, and COPD is expected to be a major market driver over the forecast period. According to the WHO, around 64 million patients are currently living with COPD worldwide with approximately 90% of deaths due to COPD occurring in low- and middle-income countries.

Furthermore, a rise in health and fitness awareness coupled with the advent of new technologies such as the Internet of Things (IoT), big data, and analytics in medical devices are the key factors that escalate the market growth. Furthermore, stressful and hectic lifestyles have resulted in the rise of several health disorders that will fuel the market's growth. The industry is also expected to witness strong growth mainly due to the rising incidents of chronic diseases, increasing adoption of pulse oximeters, other monitoring, and implantable devices; rising expenditure on healthcare across the world, and a growing elderly population.

The market witnessed a boom in demand during the pandemic which encouraged significant investments by several governments to enhance the technological advancements in the sector.

The advent of COVID-19 had a positive impact on the pulse oximeter market given the rise in the cases of the disease which encouraged the patients to opt for pulse oximeters as the hospitals were filled and many patients were treated at home. The increase in health concerns amongst customers fuelled the market in the year 2020. The Centers for Disease Prevention and Control defines severe illness of COVID-19 in people as taking more than 30 breaths per minute and having a SpO2 reading lower than 94%, on room air at sea level (or a decrease of more than 3% from a baseline reading for patients with chronic hypoxemia, a below-normal level of oxygen in the blood, specifically in the arteries). High-quality pulse oximeters are critical for the early diagnosis and treatment of patients with COVID-19. The manufacturing and supply chains of pulse oximeters are expected to witness challenges during this period, as most of the companies are working at half their production capacities.  Furthermore, trade restrictions across highly impacted countries are expected to limit the timely distribution of products. However, manufacturers are working to ensure an adequate supply of fingertip and handheld pulse oximeters to countries in dire need, as cases of COVID-19 continue to increase at an exponential rate. According to U.S Food & Drug Administration, it is informing patients and healthcare providers although pulse oximetry is useful for estimating blood oxygen levels, pulse oximeters have limitations and risks of inaccuracy under certain circumstances that should be considered. Patients with conditions such as COVID-19 who monitor their condition at home should pay attention to all signs and symptoms of their condition and communicate any concerns to their healthcare provider.

All patients with acute respiratory problems are typically monitored with pulse oximetry systems in hospitals or ambulatory surgical centres. The advancement in technology has resulted in the possibility of home monitoring for patients with underlying health conditions. The market for wearable and hand-held pulse oximeters in-home settings has therefore been robustly growing but is expected to be fuelled by COVID-19-influenced purchasing.

A substantial shift from hospitals to home care is expected to fuel the market during the forecast period.

The COVID-19 pandemic witnessed a surge in the demand for various healthcare facilities by a huge number of patients. This gradually resulted in the increasing adoption of home care services and self-care medical equipment around the world. Customers are now more attracted to portable and handy medical devices which give rapid analytics and thus an exponential rise in the demand for pulse oximeters. Even though the use of pulse oximeters in home-care settings can ease the burden on hospitals, the error margin can be high when patients without medical training attempt to interpret results. In general, doctors consider an oxygenation saturation of 95 percent and above to be normal. However, external factors such as movement artefacts and poor circulation can skew the results. Moreover, the increasing demand gave key market players the to invest in the product and come up with a more technologically advanced solution in the coming years. This is a key factor expected to drive the market during the forecast period.

Segmentation

• By Type
  • Fingertip Pulse Oximeter
  • Handheld Oximeter
  • Fetal Pulse Oximeter
  • Tabletop Pulse Oximeter
  • Wristband Pulse Oximeter
  • Pediatric Pulse Oximeter
• By End-user
  • Hospital & Clinics
  • Ambulatory Surgery Center
  • Home Care
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • UK
    • Others
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others

---

1. Introduction
1.1. Market Definition
1.2. Market Segmentation

2. Research Methodology
2.1. Research Data
2.2. Assumptions

3. Executive Summary
3.1. Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Pulse Oximeter Market Analysis, by Type    
5.1. Introduction
5.2. Fingertip Pulse Oximeter
5.3. Handheld Oximeter
5.4. Fetal Pulse Oximeter
5.5. Tabletop Pulse Oximeter
5.6. Wristband Pulse Oximeter
5.7. Pediatric Pulse Oximeter

6. Pulse Oximeter Market Analysis, by End-user    
6.1. Introduction
6.2. Hospital & Clinics
6.3. Ambulatory Surgery Center
6.4. Home Care

7. Pulse oximeter market Analysis, by Geography
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. UK
7.4.4. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. India
7.6.3. Japan
7.6.4. South Korea
7.6.5. Taiwan
7.6.6. Thailand
7.6.7. Indonesia
7.6.8. Others

8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix

9. Company Profiles 
9.1. Contec Medical Systems Co., Ltd.
9.2. GE Healthcare
9.3. Halma plc
9.4. Koninklijke Philips N.V.
9.5. Masimo Corporation
9.6. Medtronic plc
9.7. Nihon Kohden Corporation
9.8. Nonin Medical, Inc.
9.9. Omron Corporation
9.10. Smiths Group plc.

Contec Medical Systems Co., Ltd.

GE Healthcare

Halma plc

Koninklijke Philips N.V.

Masimo Corporation

Medtronic plc

Nihon Kohden Corporation

Nonin Medical, Inc.

Omron Corporation

Smiths Group plc.